364 related articles for article (PubMed ID: 35236940)
1. Cancer proteogenomics: current impact and future prospects.
Mani DR; Krug K; Zhang B; Satpathy S; Clauser KR; Ding L; Ellis M; Gillette MA; Carr SA
Nat Rev Cancer; 2022 May; 22(5):298-313. PubMed ID: 35236940
[TBL] [Abstract][Full Text] [Related]
2. Frontiers in mass spectrometry-based clinical proteomics for cancer diagnosis and treatment.
Haga Y; Minegishi Y; Ueda K
Cancer Sci; 2023 May; 114(5):1783-1791. PubMed ID: 36661476
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomics for understanding oncology: recent advances and future prospects.
Subbannayya Y; Pinto SM; Gowda H; Prasad TS
Expert Rev Proteomics; 2016; 13(3):297-308. PubMed ID: 26697917
[TBL] [Abstract][Full Text] [Related]
4. Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine.
Joshi SK; Piehowski P; Liu T; Gosline SJC; McDermott JE; Druker BJ; Traer E; Tyner JW; Agarwal A; Tognon CE; Rodland KD
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():455-479. PubMed ID: 37738504
[TBL] [Abstract][Full Text] [Related]
5. Clinical potential of mass spectrometry-based proteogenomics.
Zhang B; Whiteaker JR; Hoofnagle AN; Baird GS; Rodland KD; Paulovich AG
Nat Rev Clin Oncol; 2019 Apr; 16(4):256-268. PubMed ID: 30487530
[TBL] [Abstract][Full Text] [Related]
6. Proteogenomic interrogation of cancer cell lines: an overview of the field.
Tsang O; Wong JWH
Expert Rev Proteomics; 2021 Mar; 18(3):221-232. PubMed ID: 33877947
[No Abstract] [Full Text] [Related]
7. Current status of clinical proteogenomics in lung cancer.
Nishimura T; Nakamura H; Végvári Á; Marko-Varga G; Furuya N; Saji H
Expert Rev Proteomics; 2019 Sep; 16(9):761-772. PubMed ID: 31402712
[No Abstract] [Full Text] [Related]
8. Moonshot Objectives: Catalyze New Scientific Breakthroughs-Proteogenomics.
Rodland KD; Piehowski P; Smith RD
Cancer J; 2018; 24(3):121-125. PubMed ID: 29794536
[TBL] [Abstract][Full Text] [Related]
9. A proteogenomics data-driven knowledge base of human cancer.
Liao Y; Savage SR; Dou Y; Shi Z; Yi X; Jiang W; Lei JT; Zhang B
Cell Syst; 2023 Sep; 14(9):777-787.e5. PubMed ID: 37619559
[TBL] [Abstract][Full Text] [Related]
10. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
11. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
[TBL] [Abstract][Full Text] [Related]
12. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
[TBL] [Abstract][Full Text] [Related]
13. Proteogenomics: Key Driver for Clinical Discovery and Personalized Medicine.
Barbieri R; Guryev V; Brandsma CA; Suits F; Bischoff R; Horvatovich P
Adv Exp Med Biol; 2016; 926():21-47. PubMed ID: 27686804
[TBL] [Abstract][Full Text] [Related]
14. Methods, Tools and Current Perspectives in Proteogenomics.
Ruggles KV; Krug K; Wang X; Clauser KR; Wang J; Payne SH; Fenyö D; Zhang B; Mani DR
Mol Cell Proteomics; 2017 Jun; 16(6):959-981. PubMed ID: 28456751
[TBL] [Abstract][Full Text] [Related]
15. Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine.
Ang MY; Low TY; Lee PY; Wan Mohamad Nazarie WF; Guryev V; Jamal R
Clin Chim Acta; 2019 Nov; 498():38-46. PubMed ID: 31421119
[TBL] [Abstract][Full Text] [Related]
16. The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.
Rodriguez H; Zenklusen JC; Staudt LM; Doroshow JH; Lowy DR
Cell; 2021 Apr; 184(7):1661-1670. PubMed ID: 33798439
[TBL] [Abstract][Full Text] [Related]
17. Proteogenomic data and resources for pan-cancer analysis.
Li Y; Dou Y; Da Veiga Leprevost F; Geffen Y; Calinawan AP; Aguet F; Akiyama Y; Anand S; Birger C; Cao S; Chaudhary R; Chilappagari P; Cieslik M; Colaprico A; Zhou DC; Day C; Domagalski MJ; Esai Selvan M; Fenyö D; Foltz SM; Francis A; Gonzalez-Robles T; Gümüş ZH; Heiman D; Holck M; Hong R; Hu Y; Jaehnig EJ; Ji J; Jiang W; Katsnelson L; Ketchum KA; Klein RJ; Lei JT; Liang WW; Liao Y; Lindgren CM; Ma W; Ma L; MacCoss MJ; Martins Rodrigues F; McKerrow W; Nguyen N; Oldroyd R; Pilozzi A; Pugliese P; Reva B; Rudnick P; Ruggles KV; Rykunov D; Savage SR; Schnaubelt M; Schraink T; Shi Z; Singhal D; Song X; Storrs E; Terekhanova NV; Thangudu RR; Thiagarajan M; Wang LB; Wang JM; Wang Y; Wen B; Wu Y; Wyczalkowski MA; Xin Y; Yao L; Yi X; Zhang H; Zhang Q; Zuhl M; Getz G; Ding L; Nesvizhskii AI; Wang P; Robles AI; Zhang B; Payne SH;
Cancer Cell; 2023 Aug; 41(8):1397-1406. PubMed ID: 37582339
[TBL] [Abstract][Full Text] [Related]
18. [Precision oncology from a proteogenomics perspective].
Huang Y; Wu S; Shu K; Zhu Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3616-3627. PubMed ID: 36305397
[TBL] [Abstract][Full Text] [Related]
19. Improving Gene Annotation of the Peanut Genome by Integrated Proteogenomics Workflow.
Li H; Zhou R; Xu S; Chen X; Hong Y; Lu Q; Liu H; Zhou B; Liang X
J Proteome Res; 2020 Jun; 19(6):2226-2235. PubMed ID: 32367721
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer.
Murray HC; Dun MD; Verrills NM
Expert Opin Drug Discov; 2017 May; 12(5):431-447. PubMed ID: 28286965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
